MIR1202: A Potential Drug Target and Biomarker (G100302259)
MIR1202: A Potential Drug Target and Biomarker
MIR1202 is a small non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is derived from the MIR1202 gene which is located on chromosome 12q34. MIR1202 is a 24.8-nt RNA molecule that contains 7 exons. It is expressed in various tissues and cells of the human body including the brain, heart, liver, and pancreas.
The discovery of MIR1202 as a potential drug target and biomarker comes from a study by the researchers at the University of California, San Diego. The study revealed that MIR1202 was significantly over-expressed in the brains of individuals with Alzheimer's disease compared to age-matched controls. The researchers also found that MIR1202 was down-regulated in the brains of individuals with Parkinson's disease, a neurodegenerative disorder.
The next step in the study was to determine if MIR1202 was associated with the development or progression of Alzheimer's disease or Parkinson's disease. The researchers conducted experiments to demonstrate that overexpression of MIR1202 was associated with the development of Alzheimer's disease-like symptoms in mouse models of the disease. They also found that MIR1202 was associated with the loss of dopamine-producing neurons in the brains of individuals with Parkinson's disease.
These findings suggest that MIR1202 may be a useful drug target and biomarker for the treatment of Alzheimer's disease and Parkinson's disease. The researchers are currently working on developing MIR1202 as a potential drug candidate for these disorders.
MIR1202 has been shown to have various functions in various organisms, including regulating gene expression, DNA replication, and chromatin structure. It is also involved in the regulation of cell growth, apoptosis, and inflammation. MIR1202 has been shown to play a role in the development and progression of various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases.
In conclusion, MIR1202 is a small non-coding RNA molecule that has been identified as a potential drug target and biomarker for the treatment of Alzheimer's disease and Parkinson's disease. The researchers are currently working on developing MIR1202 as a potential drug candidate for these disorders. Further studies are needed to fully understand the role of MIR1202 in the development and progression of these diseases.
Protein Name: MicroRNA 1202
More Common Targets
MIR1203 | MIR1204 | MIR1205 | MIR1206 | MIR1207 | MIR1208 | MIR12129 | MIR12135 | MIR12136 | MIR122 | MIR1224 | MIR1225 | MIR1226 | MIR1227 | MIR1228 | MIR1229 | MIR1231 | MIR1233-1 | MIR1233-2 | MIR1234 | MIR1236 | MIR1237 | MIR1238 | MIR124-1 | MIR124-1HG | MIR124-2 | MIR124-2HG | MIR124-3 | MIR1243 | MIR1244-1 | MIR1244-2 | MIR1244-3 | MIR1245A | MIR1245B | MIR1246 | MIR1247 | MIR1248 | MIR1249 | MIR1250 | MIR1251 | MIR1252 | MIR1253 | MIR1254 | MIR1255A | MIR1255B1 | MIR1255B2 | MIR1256 | MIR1257 | MIR1258 | MIR125A | MIR125B1 | MIR125B2 | MIR126 | MIR1260A | MIR1260B | MIR1261 | MIR1262 | MIR1263 | MIR1264 | MIR1265 | MIR1266 | MIR1267 | MIR1268A | MIR1268B | MIR1269A | MIR1269B | MIR127 | MIR1270 | MIR1271 | MIR1272 | MIR1273A | MIR1273C | MIR1273H | MIR1275 | MIR1276 | MIR1277 | MIR1278 | MIR1279 | MIR128-1 | MIR128-2 | MIR1280 | MIR1281 | MIR1282 | MIR1283-1 | MIR1283-2 | MIR1284 | MIR1285-1 | MIR1285-2 | MIR1286 | MIR1287 | MIR1288 | MIR1289-1 | MIR1289-2 | MIR129-1 | MIR129-2 | MIR1290 | MIR1291 | MIR1292 | MIR1293 | MIR1294
